STAT+: ‘Learning each other’s language’: FDA, patent office seek to work together to lower drug prices
STAT
DECEMBER 7, 2023
Not long after the patent was awarded, the company leveraged federally funded research and began investigating different forms of the compound, called Revlimid. Patent & Trademark Office granted two more patents, but did not do so until 2008. And critics say this helped ring the register at the expense of the American public.
Let's personalize your content